Hepion Pharmaceuticals (HEPA) Institutional Ownership $0.32 -0.02 (-6.09%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.31 -0.01 (-3.76%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Hepion Pharmaceuticals (NASDAQ:HEPA)CurrentInstitutional OwnershipPercentage17.24%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$14.19MNumber ofInstitutional Sellers(last 12 months)0 Get HEPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HEPA Institutional Buying and Selling by Quarter Hepion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Anson Funds Management LP231,849$155K0.0%N/A3.331% 8/15/2024Armistice Capital LLC516,000$526K0.0%+32.3%9.428% 2/13/2024Armistice Capital LLC418,000$1.35M0.0%+5.1%9.631% 11/15/2023Armistice Capital LLC397,607$1.98M0.0%N/A10.360% 5/1/2023Virtu Financial LLC53,501$42K0.0%+152.8%0.070% 11/7/2022Virtu Financial LLC67,802$34K0.0%+195.6%0.089% 10/13/2022PVG Asset Management Corp107,915$55K0.2%N/A0.142% 8/12/2022Ikarian Capital LLC410,189$235K0.0%-29.5%0.538% 2/4/2022Envestnet Asset Management Inc.72,027$82K0.0%+87.5%0.094% 2/2/2022PVG Asset Management Corp100,089$114K0.4%+92.5%0.131% Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/10/2021PVG Asset Management Corp51,989$80K0.2%-72.6%0.068% 11/9/2021BlackRock Inc.1,634,012$2.50M0.0%-1.0%2.144% 11/5/2021PNC Financial Services Group Inc.39,034$60K0.0%N/A0.051% 10/13/2021Asset Management Corp IL ADV133,500$204K0.1%+45.9%0.175% 9/17/2021Virtu Financial LLC113,869$225K0.0%-36.4%0.149% 8/18/2021Ikarian Capital LLC1,365,059$2.70M0.2%N/A1.791% 8/17/2021PVG Asset Management Corp189,616$375K1.2%+1,241.0%0.249% 8/17/2021Boothbay Fund Management LLC155,069$307K0.0%N/A0.203% 8/16/2021Morgan Stanley91,106$180K0.0%+197,956.5%0.120% 8/16/2021State Street Corp322,716$639K0.0%N/A0.423% 8/16/2021Goldman Sachs Group Inc.68,399$135K0.0%N/A0.090% 8/13/2021Altium Capital Management LP446,000$883K0.2%N/A0.585% 8/13/2021Geode Capital Management LLC651,318$1.29M0.0%+10.6%0.854% 8/11/2021BlackRock Inc.1,649,929$3.27M0.0%-3.9%2.165% 8/6/2021Asset Management Corp IL ADV91,500$181K0.1%N/A0.120% 8/4/2021Envestnet Asset Management Inc.92,919$184K0.0%+256.9%0.122% 8/2/2021Advisor Group Holdings Inc.17,751$35K0.0%+94.9%0.023% 8/2/2021McAdam LLC55,978$86K0.0%+52.8%0.073% 5/19/2021Virtu Financial LLC179,030$329K0.0%N/A0.235% 5/14/2021PVG Asset Management Corp14,140$26K0.1%N/A0.019% 5/13/2021Renaissance Technologies LLC157,500$290K0.0%-52.1%0.207% 5/13/2021Bank of New York Mellon Corp48,602$89K0.0%+18.7%0.064% 5/12/2021Northern Trust Corp145,515$268K0.0%+129.5%0.191% 5/12/2021Geode Capital Management LLC588,718$1.08M0.0%+190.6%0.772% 5/12/2021UBS Group AG68,202$125K0.0%+10,794.9%0.089% 5/11/2021Rockefeller Capital Management L.P.20,000$36K0.0%N/A0.026% 5/10/2021GSA Capital Partners LLP160,775$296K0.0%+80.5%0.211% 5/7/2021BlackRock Inc.1,716,168$3.16M0.0%+43.7%2.251% 5/6/2021Prospera Financial Services Inc31,300$58K0.0%-20.4%0.041% 5/6/2021Meitav Dash Investments Ltd.44,000$81K0.0%N/A0.058% Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma5/4/2021Envestnet Asset Management Inc.26,037$48K0.0%N/A0.034% 4/28/2021 JGP Wealth Management LLC15,000$28K0.0%N/A0.020% 4/26/2021McAdam LLC36,641$67K0.0%N/A0.048% 2/16/2021Squarepoint Ops LLC111,978$245K0.0%+621.3%1.241% 2/11/2021Northern Trust Corp63,402$139K0.0%N/A0.703% (Data available from 1/1/2016 forward) HEPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HEPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Hepion Pharmaceuticals shares: Armistice Capital LLC ($526K), and Anson Funds Management LP ($155K), Virtu Financial LLC ($42K).Learn more on HEPA's institutional investors. What percentage of Hepion Pharmaceuticals stock is owned by institutional investors? 17.24% of Hepion Pharmaceuticals stock is owned by institutional investors. Learn more on HEPA's institutional investor holdings. Which institutional investors have been buying Hepion Pharmaceuticals stock? The following institutional investors have purchased Hepion Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($544K), Anson Funds Management LP ($231.85K), and Virtu Financial LLC ($32.34K). How much institutional buying is happening at Hepion Pharmaceuticals? Institutional investors have bought a total of 808,185 shares in the last 24 months. This purchase volume represents approximately $141.81M in transactions. Related Companies UPC Major Shareholders SMFL Major Shareholders EFTR Major Shareholders This page (NASDAQ:HEPA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HEPA Stock Free HEPA Stock Alerts